CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Operating activities:
Net earnings	$ 471	$ 719	$ 939
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	224	211	180
Stock-based compensation	52	50	50
Deferred income taxes	5	(32)	(2)
Goodwill, trademark and other asset impairments	0	329	0
Settlement of interest rate derivative contracts	114	0	0
Other	19	10	30
Changes in:
Receivables, net	(84)	82	(27)
Inventories, net	(18)	(282)	50
Prepaid expenses and other current assets	16	(30)	2
Accounts payable and accrued liabilities	(47)	311	291
Operating lease right-of-use assets and liabilities, net	(1)	(2)	19
Income taxes payable/prepaid	35	(90)	14
Net cash provided by operations	786	1,276	1,546
Investing activities:
Capital expenditures	(251)	(331)	(254)
Businesses acquired, net of cash acquired	0	(85)	0
Other	22	(36)	2
Net cash used for investing activities	(229)	(452)	(252)
Financing activities:
Notes and loans payable, net	237	0	(396)
Long-term debt repayments	(1,405)	0	0
Long-term debt borrowings, net of issuance costs paid	1,085	0	492
Treasury stock purchased	(25)	(905)	(248)
Cash dividends paid to Clorox stockholders	(571)	(558)	(533)
Cash dividends paid to noncontrolling interests	(15)	(31)	0
Issuance of common stock for employee stock plans and other	5	103	162
Net cash used for financing activities	(689)	(1,391)	(523)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(6)	12	(5)
Net increase (decrease) in cash, cash equivalents and restricted cash	(138)	(555)	766
Cash, cash equivalents and restricted cash:
Beginning of year	324	879	113
End of year	186	324	879
Supplemental cash flow information:
Interest paid	89	89	89
Income taxes paid, net of refunds	100	303	241
Non-cash financing activities:
Cash dividends declared and accrued, but not paid	$ 14	$ 156	$ 140